COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen of coronavirus disease 2019 (COVID-19). It is known as a respiratory virus, but SARS-CoV-2 appears equally, or even more, infectious for the olfactory epithelium (OE) than for the respiratory epithelium in the nas...
Saved in:
Main Authors: | Fengyi Liang, De Yun Wang |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b8222442ca7041e5a1ff7696e63f9dca |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anosmia y enfermedad por Coronavirus 2019 (COVID-19): ¿Qué debemos saber?
by: Sepúlveda C,Valeria, et al.
Published: (2020) -
Use of B‐complex vitamins and olfactory training for treating COVID‐19–related anosmia
by: Yethindra Vityala, et al.
Published: (2021) -
Is SARS-CoV-2 (COVID-19) postviral olfactory dysfunction (PVOD) different from other PVOD?
by: Sarah A. Imam, MD, et al.
Published: (2020) -
Anosmia, trigeminal nerve dysfunction, and COVID-19: A personal account
by: Hideaki Moteki
Published: (2021) -
Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
by: Ravi Kant, et al.
Published: (2021)